-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Platelet-Coupled IL-2 Cell Injection in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Platelet-Coupled IL-2 Cell Injection in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Platelet-Coupled IL-2 Cell Injection in Solid Tumor Drug...
-
Product Insights
G Protein Coupled Bile Acid Receptor 1 – Drugs In Development, 2023
Global Markets Direct’s G Protein Coupled Bile Acid Receptor 1 provides in depth analysis on G Protein Coupled Bile Acid Receptor 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Mas Related G Protein Coupled Receptor MRG – Drugs In Development, 2023
Global Markets Direct’s Mas Related G Protein Coupled Receptor MRG provides in depth analysis on Mas Related G Protein Coupled Receptor MRG targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Leucine Rich Repeat Containing G Protein Coupled Receptor 5 – Drugs In Development, 2023
Global Markets Direct’s Leucine Rich Repeat Containing G Protein Coupled Receptor 5 provides in depth analysis on Leucine Rich Repeat Containing G Protein Coupled Receptor 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides...
-
Sector Analysis
NewCanada Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2024 Update
Canada Source Tourism Report Overview The total outbound trips from Canada during 2023 reached 35.76 million, showing an accelerated recovery post the pandemic. The projected compound annual growth rate (CAGR) for international departures is more than 7% from 2023 to 2027. The US was the top destination market for Canadian outbound travelers in 2023. The Canada source tourism market research report provides an in-depth analysis of source markets and infrastructure developments. The report also offers an in-depth understanding of Canada's...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OKYO-0101 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OKYO-0101 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OKYO-0101 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: OKYO-0101 is...
-
Sector Analysis
NewIntraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Medulloblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Medulloblastoma Drug Details: Temozolomide (ORP-005) is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Rhabdomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Rhabdomyosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Rhabdomyosarcoma Drug Details: Temozolomide (ORP-005) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SMP-190 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SMP-190 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SMP-190 in Solid Tumor Drug Details: SMP-190 is under development for...